These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27521268)

  • 21. Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN.
    Pollard KM; Escalante GM; Huang H; Haraldsson KM; Hultman P; Christy JM; Pawar RD; Mayeux JM; Gonzalez-Quintial R; Baccala R; Beutler B; Theofilopoulos AN; Kono DH
    J Immunol; 2017 Dec; 199(11):3739-3747. PubMed ID: 29055005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The transcriptional repressor Gfi1 prevents lupus autoimmunity by restraining TLR7 signaling.
    Desnues B; Macedo AB; Ordoñez-Rueda D; Roussel-Queval A; Malissen B; Bruhns P; Malissen M; Alexopoulou L
    Eur J Immunol; 2016 Dec; 46(12):2801-2811. PubMed ID: 27600904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B cell-specific loss of Lyn kinase leads to autoimmunity.
    Lamagna C; Hu Y; DeFranco AL; Lowell CA
    J Immunol; 2014 Feb; 192(3):919-28. PubMed ID: 24376269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors.
    Takaoka A; Yanai H; Kondo S; Duncan G; Negishi H; Mizutani T; Kano S; Honda K; Ohba Y; Mak TW; Taniguchi T
    Nature; 2005 Mar; 434(7030):243-9. PubMed ID: 15665823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program.
    Negishi H; Fujita Y; Yanai H; Sakaguchi S; Ouyang X; Shinohara M; Takayanagi H; Ohba Y; Taniguchi T; Honda K
    Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15136-41. PubMed ID: 17018642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion.
    Sanjuan MA; Rao N; Lai KT; Gu Y; Sun S; Fuchs A; Fung-Leung WP; Colonna M; Karlsson L
    J Cell Biol; 2006 Mar; 172(7):1057-68. PubMed ID: 16567503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice.
    Scapini P; Lamagna C; Hu Y; Lee K; Tang Q; DeFranco AL; Lowell CA
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):E823-32. PubMed ID: 21911371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of murine macrophages via TLR2 and TLR4 is negatively regulated by a Lyn/PI3K module and promoted by SHIP1.
    Keck S; Freudenberg M; Huber M
    J Immunol; 2010 May; 184(10):5809-18. PubMed ID: 20385881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IRF5 is elevated in childhood-onset SLE and regulated by histone acetyltransferase and histone deacetylase inhibitors.
    Shu J; Li L; Zhou LB; Qian J; Fan ZD; Zhuang LL; Wang LL; Jin R; Yu HG; Zhou GP
    Oncotarget; 2017 Jul; 8(29):47184-47194. PubMed ID: 28525378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6.
    Tsantikos E; Oracki SA; Quilici C; Anderson GP; Tarlinton DM; Hibbs ML
    J Immunol; 2010 Feb; 184(3):1348-60. PubMed ID: 20042579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coordination between innate immune cells, type I IFNs and IRF5 drives SLE pathogenesis.
    Matta B; Barnes BJ
    Cytokine; 2020 Aug; 132():154731. PubMed ID: 31130331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of STAT6 promotes autoimmune disease and atopy on a susceptible genetic background.
    Lau M; Tsantikos E; Maxwell MJ; Tarlinton DM; Anderson GP; Hibbs ML
    J Autoimmun; 2012 Dec; 39(4):388-97. PubMed ID: 22867713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunity.
    Shen H; Panchanathan R; Rajavelu P; Duan X; Gould KA; Choubey D
    J Mol Cell Biol; 2010 Oct; 2(5):284-90. PubMed ID: 20802013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon regulatory factor 5 and nuclear factor kappa-B exhibit cooperating but also divergent roles in the regulation of pro-inflammatory cytokines important for the development of TH1 and TH17 responses.
    Stein T; Wollschlegel A; Te H; Weiss J; Joshi K; Kinzel B; Billich A; Guntermann C; Lehmann JCU
    FEBS J; 2018 Aug; 285(16):3097-3113. PubMed ID: 29971953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model.
    Duffau P; Menn-Josephy H; Cuda CM; Dominguez S; Aprahamian TR; Watkins AA; Yasuda K; Monach P; Lafyatis R; Rice LM; Kenneth Haines G; Gravallese EM; Baum R; Richez C; Perlman H; Bonegio RG; Rifkin IR
    Arthritis Rheumatol; 2015 Dec; 67(12):3146-57. PubMed ID: 26315890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IRF4-Dependent and IRF4-Independent Pathways Contribute to DC Dysfunction in Lupus.
    Manni M; Gupta S; Nixon BG; Weaver CT; Jessberger R; Pernis AB
    PLoS One; 2015; 10(11):e0141927. PubMed ID: 26544714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IRF5 genetic risk variants drive myeloid-specific IRF5 hyperactivation and presymptomatic SLE.
    Li D; Matta B; Song S; Nelson V; Diggins K; Simpfendorfer KR; Gregersen PK; Linsley P; Barnes BJ
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NF-κB activation via MyD88-dependent Toll-like receptor signaling is inhibited by trichothecene mycotoxin deoxynivalenol.
    Sugiyama K; Muroi M; Kinoshita M; Hamada O; Minai Y; Sugita-Konishi Y; Kamata Y; Tanamoto K
    J Toxicol Sci; 2016 Apr; 41(2):273-9. PubMed ID: 26961612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoallelic IRF5 deficiency in B cells prevents murine lupus.
    Pellerin A; Yasuda K; Cohen-Bucay A; Sandra V; Shukla P; Jr BKH; Nündel K; Viglianti GA; Xie Y; Klein U; Tan Y; Bonegio RG; Rifkin IR
    JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34197340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative regulation of Toll-like-receptor signaling by IRF-4.
    Negishi H; Ohba Y; Yanai H; Takaoka A; Honma K; Yui K; Matsuyama T; Taniguchi T; Honda K
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15989-94. PubMed ID: 16236719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.